RESUMO
Perioperative anaphylaxis is a unique condition as a result of the additive cardiovascular effects of anesthetics on the cardiovascular disturbances of anaphylaxis. It occurs mainly in adulthood, primarily follows anesthetic induction, and for the most part, is an IgE-mediated pathomechanism. Neuromuscular blocking agents (NMBAs) and antibiotics are the main culprit drugs, while latex is now infrequently involved. The Ring and Messmer scale is a useful tool for demonstrating the clinical severity of perioperative immediate hypersensitivity and guiding its management. Grades III and IV are life-threatening and are referred to as anaphylaxis. Three different clinical patterns of grade III may be observed, where cardiovascular collapse is the cardinal sign. Grade IV presents as cardiac arrest. The initial diagnosis is presumptive, whereas the etiological assessment is linked to the clinical presentation, tryptase levels, and skin test results. Since anaphylaxis presents with significant hypovolemia and vasoplegia, aggressive fluid therapy and epinephrine are the cornerstones of management. Whenever possible, anesthetic discontinuation is also recommended. Scientific evidence in favor of preemptive therapeutic strategies to prevent anaphylaxis in the operative setting is lacking.
Assuntos
Anafilaxia , Anafilaxia/epidemiologia , Antibacterianos/efeitos adversos , Epinefrina/uso terapêutico , Humanos , Látex , Bloqueadores Neuromusculares/efeitos adversos , Assistência Perioperatória , Fatores de RiscoRESUMO
BACKGROUND: Asthmatic patients with antibody deficiencies (AD) have more severe disease and higher risk of exacerbations. No data exist about the efficacy of biologics in severe asthma (SA) patients with AD. OBJECTIVE: To evaluate the efficacy of biologics in SA patients with and without AD. METHODS: A case-control real-life study was conducted including 68 patients divided into 2 groups: group 1 with SA-AD and group 2 with SA. RESULTS: Treatment with biologics for 6 months was effective for decreasing the number of exacerbations, hospitalizations, and emergency department (ED) visits and improving the Asthma Control Questionnaire (ACQ) score; biologics also proved a systemic corticosteroid-sparing effect. Despite benefits, the number of exacerbations, hospitalizations, and ED visits, the mean ACQ score, and the cumulative dose of systemic corticosteroids remain higher in group 1 than in group 2, with lower lung function parameters. The rates of responses in group 1 were inferior to those in group 2, with a decrease by ≥50% of exacerbation rate in 76% versus 97% of patients (P = .006), no hospitalization in 44% versus 91% of patients (P < .001), no ED visit in 56% versus 82% of patients (P = .018), a significant improvement of the ACQ score by ≥0.5 in 68% versus 100% of patients (P < .001), and an increase of forced expiratory volume in the first second by >10% in 32% versus 65% of patients (P = .007). CONCLUSIONS: Despite evident benefits, SA patients with AD have suboptimal responses to biologics compared with those immunocompetent. A multidisciplinary approach is necessary to optimize the management of these patients in practice.
Assuntos
Asma , Produtos Biológicos , Humanos , Asma/tratamento farmacológico , Masculino , Feminino , Pessoa de Meia-Idade , Produtos Biológicos/uso terapêutico , Adulto , Estudos de Casos e Controles , Síndromes de Imunodeficiência/tratamento farmacológico , Síndromes de Imunodeficiência/diagnóstico , Hospitalização/estatística & dados numéricos , Índice de Gravidade de Doença , Resultado do Tratamento , Idoso , Antiasmáticos/uso terapêutico , Corticosteroides/uso terapêuticoRESUMO
BACKGROUND: Early recognition of perioperative anaphylaxis, a life-threatening, usually IgE-mediated, immediate hypersensitivity, is essential, but bedside diagnosis is not always straightforward because clinical presentation may vary. OBJECTIVES: To describe early characteristics of perioperative immediate hypersensitivity, with special attention to cutaneous phenotypes, and identify risk factors for IgE-mediated allergy. METHODS: We retrospectively analyzed data from adults with suspected perioperative immediate hypersensitivity who were investigated in two academic medical centers. Multivariable logistic regression was conducted to evaluate associations among patient, clinical, and paraclinical characteristics and IgE-mediated allergy. RESULTS: Of 145 enrolled patients, 99 (68.3%) and 46 (31.7%) were respectively categorized in the IgE-mediated allergy and non-allergy groups. Cutaneous vasoconstriction phenotype (pallor, piloerection, thelerethism, and sweating with or without cyanosis) occurring within minutes (or even 1 minute) of drug exposure was strongly associated with IgE-mediated allergy (adjusted odds ratio [aOR] = 28.02; 95% CI, 4.41-305.18). IgE-mediated allergy was always life-threatening in this setting. Other early factors associated with allergy were low end-tidal carbon dioxide 25 mm Hg or less (aOR = 5.45; 95% CI, 2.39-26.45), low mean arterial pressure 60 mm Hg or less (aOR = 3.82; 95% CI, 1.28-17.31), and early cutaneous vasodilation (erythema, urticaria, and/or angioedema) (aOR = 2.78; 95% CI, 0.73-20.54). Late cutaneous vasodilation after restoration of hemodynamics corroborated the diagnosis of allergy (aOR = 23.67; 95% CI, 4.94-205.09). The best-fit model including three readily available variables (cutaneous phenotype involving the three modalities [reference lack of cutaneous signs], low mean arterial pressure, and low end-tidal carbon dioxide) had an area under the curve of 0.91. CONCLUSIONS: Cutaneous vasoconstriction phenotype is associated with the strongest risk of life-threatening allergy and thus may be regarded as pathognomonic of perioperative IgE-mediated anaphylaxis.
Assuntos
Imunoglobulina E , Período Perioperatório , Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Imunoglobulina E/sangue , Estudos Retrospectivos , Adulto , Idoso , Fatores de Risco , Anafilaxia/diagnóstico , Hipersensibilidade Imediata/diagnóstico , Hipersensibilidade Imediata/imunologia , VasoconstriçãoRESUMO
PURPOSE: Sodium hypochlorite (NaOCl) is considered as the reference irrigation solution in endodontics. However, NaOCl-related accidents may occur, and non-dentist health professionals might under-recognize this rare adverse effect although it is potentially severe, with possible medical and aesthetic sequelae. We performed a literature review to provide to non-dentist healthcare professionals a large picture of symptoms, management and potential consequences of NaOCl accidents. METHODS: We queried PubMed and the French Pharmacovigilance database and retrieved 76 cases for analysis (70 from 57 published articles, and six from the database). RESULTS: The analysis showed that patients were mostly women (79%), aged around of 42 years, undergoing upper jawbone (74%) endodontic procedure. NaOCl concentration ranged from 1% to 10%, with 0.5 to 30 mL injected. Most cases (86%) corresponded to an accidental extrusion beyond the root apex to the periapical tissues, followed by tissular injection by error (8%) and extrusion into the maxillary sinus (3%). Local symptoms always occurred within 24 h, mostly pain (99%), edema (89%) and/or ecchymosis (61%). Complications were mainly neurological (29%), necrotic (22%) and cutaneous (9%). Most of patients (76%) fully recovered after medical management but 18 (24%) required surgical management. CONCLUSION: Any healthcare professional should be aware of the classical symptomatic triad of NaOCl accident with sudden pain, haemorrhage/ecchymosis and swelling, to start or recommend adequate management. Patients should be reassured, but a close follow-up is necessary to avoid delayed complication.
Assuntos
Bases de Dados Factuais , Farmacovigilância , Irrigantes do Canal Radicular , Hipoclorito de Sódio , Humanos , Hipoclorito de Sódio/efeitos adversos , França , Feminino , Irrigantes do Canal Radicular/efeitos adversos , Masculino , Adulto , Pessoa de Meia-IdadeAssuntos
Hipersensibilidade a Drogas/fisiopatologia , Eritema Nodoso/fisiopatologia , Parada Cardíaca/fisiopatologia , Mastocitose Sistêmica/fisiopatologia , Bloqueadores Neuromusculares/efeitos adversos , Rocurônio/efeitos adversos , Anestesia Geral/efeitos adversos , Apendicectomia , Apendicite/cirurgia , Hipersensibilidade a Drogas/tratamento farmacológico , Hipersensibilidade a Drogas/etiologia , Hipersensibilidade a Drogas/imunologia , Epinefrina/uso terapêutico , Eritema Nodoso/induzido quimicamente , Eritema Nodoso/tratamento farmacológico , Eritema Nodoso/imunologia , Feminino , Parada Cardíaca/induzido quimicamente , Parada Cardíaca/tratamento farmacológico , Parada Cardíaca/imunologia , Humanos , Imunoglobulina E/sangue , Mastócitos/efeitos dos fármacos , Mastócitos/imunologia , Mastócitos/patologia , Mastocitose Sistêmica/imunologia , Pessoa de Meia-Idade , Sugammadex/uso terapêuticoRESUMO
The prevalence of anaphylaxis occurring during pregnancy is approximately 3 cases per 100,000 deliveries. The management of anaphylaxis occurring during the third trimester of pregnancy may be challenging because of the additive effects of aortocaval compression and cardiovascular disturbances of anaphylaxis. In this review, we identify the clinical signs of anaphylaxis occurring during labor and cesarean delivery, discuss the more common allergens that cause anaphylaxis during this clinical setting, and develop a rational approach to the identification of the offending allergen. We also suggest strategies for the management of anaphylaxis occurring during the third trimester of pregnancy, including the prompt administration of epinephrine and emergency cesarean delivery in cases of severe reactions. Evidence is limited to case reports and extrapolation from nonfatal and fatal cases, interpretation of pathophysiology, and consensus opinion.
Assuntos
Anafilaxia/epidemiologia , Anestesia Obstétrica/efeitos adversos , Complicações na Gravidez/epidemiologia , Anafilaxia/diagnóstico , Anafilaxia/mortalidade , Anafilaxia/fisiopatologia , Anafilaxia/terapia , Anestesia Obstétrica/mortalidade , Antialérgicos/administração & dosagem , Cesárea/efeitos adversos , Epinefrina/administração & dosagem , Feminino , Humanos , Trabalho de Parto , Gravidez , Complicações na Gravidez/diagnóstico , Complicações na Gravidez/mortalidade , Complicações na Gravidez/fisiopatologia , Complicações na Gravidez/terapia , Terceiro Trimestre da Gravidez , Fatores de Risco , Índice de Gravidade de Doença , Resultado do TratamentoRESUMO
PURPOSE: We report a case of drug-induced immediate hypersensitivity occurring after atracurium injection in a patient with cutaneous mastocytosis. CLINICAL FEATURES: A 69-yr-old woman was scheduled for hysterectomy. She was premedicated with hydroxyzine, and anesthesia was induced with sufentanil, propofol, and atracurium. Within two to three minutes following the injection of atracurium, the patient experienced an episode of generalized erythema and arterial hypotension associated with tachycardia. No bronchospasm was observed. Her cardiovascular signs resolved spontaneously within five minutes, while her cutaneous signs disappeared within 30 min. Anesthesia and surgery remained uneventful. The patient's serum tryptase levels were measured at different time points following the clinical reaction. An in vitro flow cytometry-based basophil activation test was performed with atracurium, and in vivo skin tests to latex and all drugs which were administered just before the clinical reaction were also done. The serum tryptase showed increased concentrations that remained elevated for 24 hr, 48 hr, and even four weeks after the clinical reaction. Atracurium did not induce either CD63 or CD203c upregulation, and the skin tests were negative in response to the medications received (propofol, sufentanil, and atracurium) as well as to latex. CONCLUSIONS: Allergic hypersensitivity to atracurium was ruled out. Increased tryptase concentrations following the clinical reaction, persistent increased levels of basal serum tryptase, and negative skin tests suggested the onset of mast cell degranulation in a patient with mastocytosis. Immediate reaction occurring in patients with mastocytosis should be investigated in order to identify the mechanism of the reaction, either histamine release due to the disease itself or due to a concurrent drug/agent-induced IgE-mediated mechanism.
Assuntos
Atracúrio/efeitos adversos , Hipersensibilidade a Drogas/etiologia , Mastocitose Cutânea/complicações , Fármacos Neuromusculares não Despolarizantes/efeitos adversos , Idoso , Atracúrio/administração & dosagem , Atracúrio/uso terapêutico , Feminino , Citometria de Fluxo , Humanos , Histerectomia/métodos , Complicações Intraoperatórias/induzido quimicamente , Fármacos Neuromusculares não Despolarizantes/administração & dosagem , Fármacos Neuromusculares não Despolarizantes/uso terapêutico , Triptases/sangueRESUMO
Apical ballooning syndrome, a reversible left ventricle dysfunction, has been reported following anaphylaxis and, during this clinical circumstance, is seemingly linked to the use of either low or high doses of epinephrine. We report a severe succinylcholine-induced IgE-mediated anaphylaxis in a 65-year-old woman, in whom the diagnosis of apical ballooning syndrome following anaphylaxis was established. As a thorough description of the clinical features and resuscitative measures could be obtained, we discuss the reasons for apical ballooning syndrome occurrence and highlight the fact that optimal care management of anaphylaxis should include a progressive titration of epinephrine.
Assuntos
Anafilaxia/complicações , Epinefrina/efeitos adversos , Fármacos Neuromusculares Despolarizantes/efeitos adversos , Succinilcolina/efeitos adversos , Cardiomiopatia de Takotsubo/etiologia , Idoso , Anafilaxia/tratamento farmacológico , Feminino , Humanos , Imunoglobulina E/imunologiaRESUMO
PURPOSE OF REVIEW: During the preoperative evaluation, patients frequently indicate 'multiple drug allergies', most of which have not been validated. Potential allergic cross-reactivity between drugs and foods is frequently considered as a risk factor for perioperative hypersensitivity. The aim of this review is to facilitate the recognition of risk factors for perioperative anaphylaxis and help the management of patients with 'multiple drug allergies' during the perioperative period. RECENT FINDINGS: Neuromuscular blocking agents (NMBAs) and antibiotics are the most common drugs triggering perioperative anaphylaxis. Quaternary ammonium ions have been suggested to be the allergenic determinant of NMBAs. Even though the 'pholcodine hypothesis' has been suggested to explain the occurrence of NMBA-induced allergy, this concept remains unclear. Although many practitioners believe that certain food allergies present an issue with the use of propofol, there is no role to contraindicate propofol in egg-allergic, soy-allergic or peanut-allergic patients. IgE-mediated hypersensitivity has been reported with seafood and iodinated drugs, IgE-mediated hypersensitivity has been reported with seafood and iodinated drugs, but there is no cross-reactivity between them. The allergenic determinants have been characterized for fish, shellfish and povidone iodine and remain unknown for contrast agents. SUMMARY: There are many false assumptions regarding drug allergies. The main goal of this article is to review the potential cross-reactivity among specific families of drugs and foods in order to facilitate the anesthetic management of patients with 'multiple drug allergies'.
Assuntos
Anestesia/efeitos adversos , Anestésicos/efeitos adversos , Hipersensibilidade a Drogas/fisiopatologia , Analgésicos/efeitos adversos , Analgésicos/imunologia , Anafilaxia/terapia , Anestésicos Intravenosos/efeitos adversos , Animais , Antibacterianos/efeitos adversos , Antibacterianos/imunologia , Codeína/efeitos adversos , Codeína/análogos & derivados , Codeína/imunologia , Meios de Contraste/efeitos adversos , Reações Cruzadas , Hipersensibilidade a Ovo/imunologia , Peixes , Hipersensibilidade Alimentar/complicações , Hipersensibilidade Alimentar/epidemiologia , Humanos , Hipersensibilidade Imediata/fisiopatologia , Compostos de Iodo/efeitos adversos , Carne/efeitos adversos , Morfolinas/efeitos adversos , Morfolinas/imunologia , Bloqueadores Neuromusculares/efeitos adversos , Hipersensibilidade a Amendoim/complicações , Período Perioperatório , Propofol/efeitos adversos , Fatores de Risco , Alimentos Marinhos/efeitos adversos , Glycine max/efeitos adversosRESUMO
BACKGROUND: Vital dyes are widely used for lymphatic mapping and sentinel lymph node biopsy in patients with malignant tumors, and reports of anaphylactic reactions are becoming more frequent. OBJECTIVE: Our aims were to describe specific clinical features of hypersensitivity reactions to Patent Blue (Guerbet, Roissy, France), results of the allergy workup, and their consequences for patient management. METHODS: We report a series of 14 clinical cases of dye-induced anaphylaxis recorded between 2004 and 2006 in 4 member centers of a network of French allergoanesthesia outpatient clinics. RESULTS: Reactions appeared to be relatively severe (6/14 grade III reactions). An average 30 +/- 6-minute delay was observed between dye injection and symptom onset. In 9 (65%) patients reactions were sustained for several hours, requiring prolonged continuous epinephrine infusion and transfer to an intensive care unit. Prick test results were positive in 8 patients. In 5 patients prick test results were negative, whereas intradermal test results were positive. CONCLUSION: Anesthesiologists and allergologists must be aware of this specific risk and of the clinical characteristics of these reactions, which are usually delayed and long lasting.
Assuntos
Anafilaxia/induzido quimicamente , Corantes/efeitos adversos , Corantes de Rosanilina/efeitos adversos , Adulto , Idoso , Anafilaxia/imunologia , Feminino , França , Humanos , Masculino , Pessoa de Meia-Idade , Assistência Perioperatória , Corantes de Rosanilina/química , Corantes de Rosanilina/imunologiaRESUMO
PURPOSE OF REVIEW: Anaphylactic reactions occurring during anaesthesia may be life threatening. Lethal issues may be involved in up to 3-10% of the cases. The allergological assessment (including biochemical tests and skin tests) is the key to the management of these reactions. The scope of this review is to focus on the allergological assessment required to prove the immune mechanism, to identify the culprit drug or substance and the cross-reactive molecules, especially for neuromuscular blocking agents, allowing preventive measures for future anaesthetic procedures. RECENT FINDINGS: To describe the allergological assessment (including biochemical tests and skin tests performed according to the current guidelines) in order to prove the immune mechanism as the responsibility of the culprit allergen. The most frequent and less frequent drugs involved are described. The different biological tools available are detailed. To ensure an accurate diagnosis, the interpretation of the allergological assessment should be linked to the description of the clinical events as their time onset following the injection/administration of the suspected drug(s)/substance. SUMMARY: To describe the different tools (biochemical tests and skin tests) available in order to prove the diagnosis of an anaphylactic reaction occurring during anaesthesia.
Assuntos
Anafilaxia , Anestesia , Hipersensibilidade a Drogas , Bloqueadores Neuromusculares/efeitos adversos , Anafilaxia/etiologia , Anafilaxia/prevenção & controle , Reações Cruzadas , Hipersensibilidade a Drogas/etiologia , Hipersensibilidade a Drogas/prevenção & controle , Humanos , Assistência Perioperatória/métodos , Testes CutâneosRESUMO
BACKGROUND: Neuromuscular blocking agents (NMBAs) are the main agents involved during perioperative immediate hypersensitivity. The etiological diagnosis (IgE-mediated allergy vs nonallergy) is linked to the clinical presentation together with tryptase and histamine levels and skin test results. The role of basophil activation test (BAT) needs to be better defined in this setting. OBJECTIVES: To assess the role of BAT compared with the results of skin testing in 31 patients experiencing immediate NMBA hypersensitivity and compare skin test results and BAT performances in the identification of alternative NMBAs. METHODS: Histamine and tryptase levels were quantified. Anesthetic drugs, including NMBAs, were skin-tested. Basophil CD63 and CD203c expressions were measured in response to serial dilutions of the different NMBAs. RESULTS: Allergy and Nonallergy groups involved 19 and 12 patients, respectively. Circulating histamine and tryptase levels were significantly increased in allergic patients. In the Allergy group, while skin test results were positive in 100% (19 of 19) of the cases, BAT positivity to the culprit NMBA reached 78.9% (15 of 19) when combining CD63 and CD203c. NMBAs cross-reactivity was identified through skin testing and BAT in 36.8% (7 of 19) and 26.3% (5 of 19) of the cases, respectively. The concordance (culprit and cross-reactive NMBAs) between skin tests and BATs was between 73.6% (14 of 19) and 100% (19 of 19) for each NMBA. Negative skin-tested NMBAs were uneventfully used in 7 NMBA-allergic patients. In the Nonallergy group, skin test results were negative in 100% of the cases while BAT result was positive once (CD63 upregulation). CONCLUSION: In our technical conditions, BAT does not replace skin testing in the assessment of NMBA allergy.
Assuntos
Alérgenos/imunologia , Teste de Degranulação de Basófilos/métodos , Hipersensibilidade a Drogas/diagnóstico , Bloqueadores Neuromusculares/imunologia , Testes Cutâneos/métodos , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Histamina/sangue , Humanos , Hipersensibilidade Imediata , Imunoglobulina E/metabolismo , Masculino , Pessoa de Meia-Idade , Gravidez , Triptases/sangueRESUMO
BACKGROUND: Iodinated and gadolinium-based contrast media (ICM; GBCM) induce immediate hypersensitivity (IH) reactions. Differentiating allergic from non-allergic IH is crucial; allergy contraindicates the culprit agent for life. We studied frequency of allergic IH among ICM or GBCM reactors. METHODS: Patients were recruited in 31 hospitals between 2005 and 2009. Clinical symptoms, plasma histamine and tryptase concentrations and skin tests were recorded. Allergic IH was diagnosed by intradermal tests (IDT) with the culprit CM diluted 1:10, "potentially allergic" IH by positive IDT with pure CM, and non-allergic IH by negative IDT. FINDINGS: Among 245 skin-tested patients (ICMâ¯=â¯209; GBCMâ¯=â¯36), allergic IH to ICM was identified in 41 (19.6%) and to GBCM in 10 (27.8%). Skin cross-reactivity was observed in 11 patients with ICM (26.8%) and 5 with GBCM (50%). Allergy frequency increased with clinical severity and histamine and tryptase concentrations (pâ¯<â¯0.0001). Cardiovascular signs were strongly associated with allergy. Non-allergic IH was observed in 152 patients (62%) (ICM:134; GBCM:18). Severity grade was lower (pâ¯<â¯0.0001) and reaction delay longer (11.6 vs 5.6â¯min; pâ¯<â¯0.001). Potentially allergic IH was diagnosed in 42 patients (17.1%) (ICM:34; GBCM:8). The delay, severity grade, and mediator release were intermediate between the two other groups. INTERPRETATION: Allergic IH accounted for < 10% of cutaneous reactions, and > 50% of life-threatening ones. GBCM and ICM triggered comparable IH reactions in frequency and severity. Cross-reactivity was frequent, especially for GBCM. We propose considering skin testing with pure contrast agent, as it is more sensitive than the usual 1:10 dilution criteria.
RESUMO
Bariatric surgery is increasingly performed for effective weight loss. A morbidly obese 27-year-old woman underwent laparoscopoic adjustable gastric banding. After a postoperative adjustment of the stomal diameter of the band with ioxaglate, she presented an immediate hypersensitivity reaction. With the patient's consent, cutaneous tests to contrast agents used during the procedure and to latex were performed. Allergy to ioxaglate was confirmed by skin-test positivity. This case suggests the need for allergological investigation of drugs/substances administered during the perioperative period, in case of hypersensitivity reaction.
Assuntos
Meios de Contraste/efeitos adversos , Hipersensibilidade a Drogas/etiologia , Gastroplastia , Ácido Ioxáglico/efeitos adversos , Adulto , Meios de Contraste/administração & dosagem , Feminino , Humanos , Ácido Ioxáglico/administração & dosagem , Obesidade Mórbida/cirurgiaAssuntos
COVID-19 , Toxidermias , Vacina BNT162 , Toxidermias/diagnóstico , Toxidermias/etiologia , HumanosAssuntos
Anestesia/efeitos adversos , Anestésicos Intravenosos/efeitos adversos , Espasmo Brônquico/induzido quimicamente , Fármacos Neuromusculares Despolarizantes/efeitos adversos , Succinilcolina/efeitos adversos , Adulto , Albuterol/uso terapêutico , Anti-Inflamatórios/uso terapêutico , Espasmo Brônquico/tratamento farmacológico , Broncodilatadores/uso terapêutico , Dióxido de Carbono/sangue , Diabetes Mellitus Tipo 2/complicações , Diagnóstico Diferencial , Epinefrina/uso terapêutico , Feminino , Humanos , Hidrocortisona/uso terapêutico , Hipotensão/induzido quimicamente , Hipotensão/tratamento farmacológico , Intubação Intratraqueal , Soluções Isotônicas/uso terapêutico , Máscaras Laríngeas , Complacência Pulmonar , Fármacos Neuromusculares Despolarizantes/administração & dosagem , Obesidade Mórbida/complicações , Oxigênio/sangue , Propofol/administração & dosagem , Solução de Ringer , Succinilcolina/administração & dosagem , Sufentanil/administração & dosagem , Taquicardia/induzido quimicamente , Taquicardia/tratamento farmacológicoRESUMO
"Iodine allergy" does not exist. The concept of "iodine allergy" should be abandoned since it may result in inappropriate measures such as drug, food or environmental eviction. Immediate or non-immediate allergic hypersensitivity to iodinated contrast media is not infrequent. The corresponding allergens have not been identified. Iodine is not involved. Immediate or non-immediate allergic hypersensitivity to povidone iodine is rare. The corresponding allergen is povidone in case of immediate hypersensitivity while nonoxynol might be involved during non-immediate hypersensitivity. Seafood allergens belong to a group of muscle proteins. Immediate drug hypersensitivity or food hypersensitivity is assessed by immediate-reading skin tests while non-immediate drug hypersensitivity is investigated by delayed-reading skin testing. Combined histamine and tryptase measurement is invaluable during the diagnostic approach of immediate hypersensitivity. Other biological tests are being evaluated. Allergic hypersensitivity to iodinated contrast agents does not contraindicate the use of other iodinated drugs.